EMA: EVIDENCE ON HETEROLOGOUS VACCINATION SUGGESTS COMBINATION OF VIRAL VECTOR VACCINES, MRNA VACCINES PRODUCES HIGHER T-CELL RESPONSE VS SAME VACCINE WHETHER IN PRIMARY OR BOOSTER REGIMEN